| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10818250 | Clinical Biochemistry | 2005 | 6 Pages |
Abstract
Our results demonstrate that the CYP3A5*1 allele, previously reported as a marker for CYP3A5 expression in human kidney, is associated with increased risk for BEN, while CYP3A4*1B and CYP2D6 genotypes do not significantly modify the risk for the disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Srebrena Y. Atanasova, Nicolas von Ahsen, Draga I. Toncheva, Tzvetan G. Dimitrov, Michael Oellerich, Victor W. Armstrong,